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Keratinocytes are an integral component of the skin
immune system and function as nonprofessional
antigen-presenting cells in pathophysiologic condi-
tions when they express major histocompatibility
complex class II molecules, e.g., in psoriasis. In order
to analyze further this function we investigated the
activity of cathepsin S in comparison with cathepsins
B and L. These enzymes were suggested to be
involved in antigen presentation. Speci®c catalytic
activities of these cathepsins were determined ¯uoro-
metrically by hydrolysis of a synthetic substrate (Z-
Phe-Arg-7-amido-4-methylcoumarin) in subcellular
fractions of human keratinocytes. It was found that
the human keratinocyte cell line HaCaT exhibits
activities of all three cathepsins investigated.
Endosomal/lysosomal compartments show highest
cathepsin activities. Normal human keratinocytes in
primary culture show a comparable pattern of cathe-
psin activities. In contrast to this, in syngeneic
Epstein±Barr virus-transformed B cells the level of
cathepsin B activity was found to be 10% of that in
the corresponding keratinocytes, whereas the activ-
ities for cathepsins L and S were in a similar range.
Interferon-g stimulation of primary keratinocytes and
HaCaT cells resulted in a selective upregulation of the
cathepsin S activity, the extent of which was very
similar. The mechanism of this upregulation was
demonstrated as induction at the mRNA and protein
levels. This report documents that cathepsin S in
human keratinocytes is selectively upregulated, in
parallel to major histocompatibility complex class II
molecules, in response to a pro-in¯ammatory cyto-
kine. Our observations support the concept of kerati-
nocytes functioning as nonprofessional antigen-
presenting cells in states of in¯ammation. Key words:
antigen presentation/antigen processing/cathepsins B, L, S/
psoriasis. J Invest Dermatol 119:44±49, 2002
T
he task of immune surveillance and immune responses
as an integral part of the barrier function of the skin is
mirrored by the complex composition of the so-called
``skin immune system'' (Bos and Kapsenberg, 1986).
In order to mount a speci®c immune response this
system needs to generate antigenic peptides and to present them in
a fashion allowing stimulation of lymphocytes, a function usually
performed by professional antigen-presenting cells, e.g., Langerhans
cells, which are characterized by their major histocompatibility
complex (MHC) class II positive phenotype (Germain, 1994).
Cytokine stimulation in vitro or the state of in¯ammation in vivo,
however, results in the induction of MHC class II expression on a
variety of endothelial and epithelial cells, including keratinocytes
(Gottlieb et al, 1986). This phenomenon for which interferon-
(IFN)g seems to play a key part (Kerr et al, 1990; Albanesi et al,
1998) turns keratinocytes into nonprofessional antigen-presenting
cells (Nickoloff and Turka, 1994).
Besides MHC class II expression for antigen presentation the
ability for peptide processing is relevant for a cell to ful®ll the
function of an antigen-presenting cell effectively. Generation of
antigenic peptides, as intracellular protein degradation in general,
involves a family of endosomal/lysosomal proteases called cathep-
sins. Cathepsins can initiate antigen processing by generating larger
fragments containing antigenic epitopes, the respective fragments
are subsequently trimmed to their ®nal size by exopeptidases
(Fineschi and Miller, 1997). For the generation of T helper cell
epitopes from ovalbumin and myoglobin involvement of cathepsins
B, D, and L has been demonstrated (Takahashi et al, 1989;
Van Noort and van der Drift, 1989; Diment, 1990). Additionally,
cathepsin S may be of particular relevance in the context of antigen
processing as it is known to degrade the invariant chain to class II
associated invariant chain peptide, an important step for the correct
loading of MHC class II molecules with antigenic peptides and
subsequent surface expression of this complex (Riese et al, 1996).
To analyze further the role of keratinocytes as nonprofessional
antigen-presenting cells of the skin immune system the activity of
cathepsins S was determined in comparison with the activities of
cathepsins B and L presumably relevant for antigen presentation in
human keratinocytes. In addition, these enzyme activities were
compared with those of the professional antigen-presenting B cells.
Qualitative similarities were observed in the pattern of cathepsin
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activities in syngeneic keratinocytes and B cells and selective
upregulation of cathepsin S activity in IFN-g-stimulated keratino-
cytes.
MATERIALS AND METHODS
Cells The HaCaT line of spontaneously immortalized human
keratinocytes (Boukamp et al, 1988) was a kind gift from Prof. Fusenig
(German Cancer Research Center, Heidelberg) and was maintained in
RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum,
penicillin 100 IU per ml, 100 mg streptomycin per ml or 130 mg
gentamycin per ml (Gibco Life Technologies, Paisley, U.K.). Normal
human keratinocytes were derived from the foreskin of one patient (or
collected from four patients) who underwent circumcision and cultured
according to the method of Rheinwald and Green (1975) in keratinocyte
growth medium (Promo Cell, Heidelberg, Germany) supplemented with
bovine pituitary extract (Gibco Life Technologies) as recommended,
100 IU penicillin per ml and 100 mg streptomycin per ml or MCDB 153
medium (Sigma, Deisenhofen, Germany) and supplemented according to
Meier et al, 2000. HaCaT cells and normal keratinocytes were cultured
in a humidi®ed atmosphere containing 5% CO2 at 37°C. Epstein±Barr
virus (EBV)-transformed B cells were established from peripheral
mononuclear cells of the same individual, who underwent circumcision,
and cultured in RPMI 1640 with 10% heat-inactivated fetal bovine
serum in roller bottles at 37°C. HaCaT cells as well as keratinocytes
were stimulated for 72 h with recombinant human IFN-g at a
concentration of 1000 units per ml (Thomae, Biberach and Strathmann
Biotech GmbH, Hamburg, Germany).
Fluorescence-activated cell sorter analyses To characterize further
the effects of IFN-g on the antigen presenting abilities of keratinocytes
expression of HLA class I and class II molecules as well as invariant chain
was investigated by means of ¯uorescence-activated cell sorter analyses
(FACScan, Becton-Dickinson, Mountain View, CA). The following
mouse anti-human monoclonal antibodies were used: W6/32 detecting
HLA-A, -B, and -C (ATCC, Manassas, VA); L243 detecting HLA-DR
(ATCC, Manassas, VA); FA for HLA-DP (ATCC, Manassas, VA);
TUÈ 22 for HLA-DQ, and SD3253.74 for invariant chain. The antibodies
TUÈ 22 and SD3253.74 were kindly provided to us by Prof. Dr Claudia
A. MuÈller/Department of Medicine of the University of TuÈbingen.
Cell fractionation As the cellular cytosol contains strong cathepsin
inhibitors (Abrahamson, 1994), the enzyme activities were determined in
whole cell lysates as well as in different cellular compartments. Cell
fractionation was performed by differential centrifugation as described by
SchroÈter et al (1999). Brie¯y, the different cell preparations (at least 20±
40 millions cells each) were collected, washed, and homogenized in an
Elvehjem-Potter containing a homogenization buffer (250 mM sucrose,
10 mM Tris, pH 7.2), followed by centrifugation (Beckman TL 100
ultracentrifuge). The following fractions were obtained: debris (4000 3 g
for 2 min), mitochondria and endosomes/lysosomes (100,000 3 g for
2 min), microsomes (400,000 3 g for 12 min), and cytosol (supernatant).
Lysosomes were separated from endosomes by hypotonic lysis using 2.5
times of the pellet volume for keratinocytes and ®ve times of the pellet
volume in the case of B cells, followed by repeated centrifugation with
100,000 3 g for 4 min. In addition, a crude organelle fraction was
prepared by omitting the second centrifugation step (100,000 3 g for
2 min). The pellet obtained after centrifugation at 400,000 3 g for
12 min consists of mitochondria, endosomes, lysosomes, and
microsomes.
N-acetyl-b-D-glucosaminidase (NAG) assay As NAG is a good
marker for endosomal/lysosomal compartments, determination of NAG
activity was used to control the quality of the cell fractionation using a
method described by Schmid et al (1993): Aliquots are added to 100 ml of
0.1 M citrate buffer (pH 5.0; 2±50 ng protein per ml) containing 0.8 mM
4-methylumbelliferyl-N-acetyl-b-D-glucosaminide (Sigma, Deisenhofen,
Germany) and 0.1±1% Triton X100. Fluorescence was measured every
8 min at 37°C using a ¯uorescence reader (Tecan SpectraFluor,
Crailsheim, Germany; excitation wavelength 360 nm, emission wave-
length 465 nm). NAG activity was determined by linear regression using a
minimum of four measurement points. 4-methylumbelliferone was used
for calibration.
Determination of cathepsin activities Speci®c catalytic activities of
cathepsins B, L, and S were determined ¯uorometrically by hydrolysis of
the synthetic substrate Z-Phe-Arg-7-amido-4-methylcoumarin (Bachem,
Bubendorf, Switzerland) (Morita et al, 1977) according to Schmid et al
(1997) with the following variations. For total cathepsin activity (B, L,
and S), 100 ml of 0.1 M citrate buffer pH 5.0 containing 4 mM
dithiothreitol, 4 mM ethylenediamine tetraacetic acid, and 6 mM
aprotinin were used; an aliquot probe (2±50 ng protein per ml) was
added and the reaction was started with substrate solution (500 mM).
The liberated ¯uorescence was measured at 37°C every 10 min with a
¯uorescence reader (Tecan SpectraFluor; excitation wavelength 360 nm,
emission wavelength 465 nm). Activities were determined by linear
regression using a minimum of four measurement points. Addition of the
speci®c inhibitor CA074 (10 mM; Bachem, Bubendorf, Switzerland)
(Towatari et al 1991) to the same reagent yielded cathepsin B activity
(inhibited activity). The remaining activity was con®rmed to be
cathepsin L activity by inhibition with 0.5 mM Z-Phe-
Phediazomethylketone in a separate experiment. For determination of
cathepsin S activity an aliquot probe was preincubated with 0.1 M
phosphate buffer (pH 7.5) containing 4 mM dithiothreitol, 4 mM
ethylenediamine tetraacetic acid, 6 mM aprotinin at 37°C for 1 h (0.1±
1.2 mg protein per ml). By this procedure inactivation of cathepsins B
and L was achieved (Kirschke et al, 1989; Schmid et al, 1997). After
adding substrate solution (500 mM) incubation for 60 min yielded
cathepsin S activity, which was inhibited by 5 nM morpholineurea-
leucinyl-homophenalanyl-vinylsufone-phenyl (Palmer et al, 1995; Riese
et al, 1996).
Complete inhibition of these enzyme activities by E-64 (10 mM;
Boehringer Mannheim, Mannheim, Germany; Hanada et al, 1978)
con®rmed the detection of cysteine proteinase activities. Amido-4-
methylcoumarin (Bachem, Heidelberg, Germany) was used for calibra-
tion. The activity determinations were performed in duplicate.
Protein concentrations were determined by a modi®ed method of
Bradford. Roti-Nanoquant solution (Roth, Karlsruhe, Germany) and
bovine serum albumin as standard for quanti®cation were used. Speci®c
enzyme activities were expressed as mmol per min per g of protein.
Reverse transcription±polymerase chain reaction (reverse tran-
scription±PCR) of human cathepsin S (When not explicitly
mentioned all materials used were from Peqlab, Erlangen, Germany.)
Total RNA was isolated from keratinocytes (controls and stimulated with
1000 U IFN-g per ml for 24 h) with EZNA total RNA kit. In both
cases 1 mg total RNA was mixed with 250 ng oligo(dT) primer
(Stratagene, Amsterdam, the Netherlands) in a ®nal volume of 10 ml of
diethyl pyro carbonate-treated water, heated to 65°C for 10 min and
cooled on ice. Reverse transcription was performed in a ®nal volume of
20 ml of 10 3 reverse transcriptase buffer containing dithiothreitol
(2.5 mM), deoxyribonucleoside triphosphate (1.25 mM) and 25 units of
avian myeloblastosis virus reverse transcriptase. Samples were incubated
for 1 h at 42°C and cooled on ice. The PCR was initiated by pipetting
2±6 ml of the cDNA (100±500 ng), 10 3 Taq buffer, deoxyribo-
nucleoside triphosphate (0.2 mM), 50 pmol each of forward and reverse
primer, 2 units Taq polymerase and sterile water to a ®nal volume of
50 ml. Ampli®cation was done over 35 cycles with a thermal cycler
(Applied Biosystems 9700, Norwalk, CT). Each cycle consisted of
following steps: denaturation at 94°C, annealing at 56°C and extension
at 72°C for 30 s each. PCR products were identi®ed by 2% agarose gel
electrophoresis.
The following sets of oligonucleotide primers were used to amplify
cDNA: human cathepsin S 5¢ CAGGAAAGCTGGTGACTCTCAG 3¢
and 5¢ TCTGGGTAAGAGGGAAAGCTAGC 3¢ (GenBank accession
number XM-002028), human b-actin 5¢ TCAGAAGGATTCCTA-
TGTGGGC 3¢ and 5¢ CCATCACGATGCCAGTGGTA 3¢ (GenBank
accession number NM-001101). The length of cathepsin S DNA
segments to be ampli®ed were 500 bp. Primer pairs amplifying a 300 bp
segment of the human b-actin gene were chosen as a positive control for
the reverse transcription.
Western blotting Sodium dodecyl sulfate±polyacrylamide gel
electrophoresis of subcellular keratinocyte fractions (8±15 mg protein)
was carried out in a 12% gel followed by electroblotting on to
polyvinylidene di¯uoride membrane (Amersham-Pharmacia, Amersham,
Buckinghamshire, U.K.) using a tank transfer unit. After treatment with
milk powder the membrane was incubated with polyclonal rabbit
antibody against cathepsin S (1:3000) (E. Weber, Halle, Germany) and
anti-rabbit antibody conjugated with horseradish peroxidase (Dianova,
Hamburg, Germany). Signals were detected by chemiluminescence
(ECL-Plus detection kit, Amersham-Pharmacia).
RESULTS
Activities of cathepsins B, L, and S in HaCaT keratino-
cytes Initially, we attempted to establish the cathepsin activity
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pattern in control HaCaT keratinocytes (Table I). Cathepsin B
activity of the different fractions contributed about 90% of the total
cathepsin activities, followed by cathepsin L (about 10%), whereas
cathepsin S accounted for less than 0.2% of total cathepsin activity
ranging at the detection limits. In analogy to the endosomal/
lysosomal marker enzyme NAG, we found highest activity of the
three cathepsins in endosomal and especially lysosomal fractions.
The ratio of endosomal and lysosomal activities of all four enzymes
was very similar with an approximately 5-fold level found in
lysosomes.
Activities of cathepsins B, L, and S in normal human
keratinocytes in comparison with those in syngeneic
B cells As HaCaT keratinocytes are spontaneously immortal-
ized cells we compared their cathepsin activities with those of
human keratinocytes in primary culture, obtained from one patient
who had undergone circumcision. In these cells the activities of the
three cathepsins ranged in the same order of magnitude as in
HaCaT cells (Table II). Again, the most abundant protease activity
was that of cathepsin B followed by cathepsins L and S. In contrast
to HaCaT keratinocytes NAG activities of primary keratinocytes
were found to be essentially higher than cathepsin B activities.
In order to compare the cathepsin activities found in keratino-
cytes we determined these enzyme activities in professional
antigen-presenting cells. For this purpose, EBV-transformed
B cells were derived from peripheral mononuclear cells of the
same patient who had undergone circumcision. Interestingly, the
B cells exhibited about 10% of cathepsin B activity in whole cell
homogenate as well as in subcellular fractions as compared with
cathepsin B activities in syngeneic keratinocytes. Cathepsin L
activity was close to the level detected in the keratinocytes, with a
similar distribution pattern as compared with that of cathepsin B
and NAG activities. Again, the lowest activity levels were found for
cathepsin S, which were similar to those of keratinocytes. By this
way, in the EBV-transformed B cells the percentage of cathespin S
activity relative to total activity of cathespins B and L with 0.8% and
1.4% in whole cell homogenate and lysosomal fraction, respectively
and 5.1% in the endosomal fraction becomes higher than in the
syngeneic keratinocytes. This relatively high endosomal cathepsin S
activity is 50% of lysosomal cathepsin S activity, whereas this
percentage was essentially lower in primary keratinocytes and
HaCaT keratinocytes.
Selective upregulation of cathepsin S activity in human
keratinocytes and in HaCaT keratinocytes by IFN-g
Although keratinocytes do not express MHC class II molecules
constitutively, exposure to IFN-g can induce their expression thus
enabling them to function as nonprofessional antigen-presenting
cells. We therefore investigated the in¯uence of this pro-
in¯ammatory cytokine on MHC class I and II expression.
Furthermore, we examined cathepsin activities of human
keratinocytes in primary culture in comparison with those in the
permanent human keratinocyte line HaCaT under these
conditions.
The constitutive expression of MHC class I was increased by
incubation with 1000 units per ml over a period of 72 h.
Additionally, low levels of HLA-DQ and HLA-DP neo-expression
along with a profound surface neo-expression of HLA-DR were
detectable following IFN-g stimulation. Moreover, strong intra-
cellular staining for the invariant chain was also seen (Fig 1).
Interestingly, IFN-g treatment (Table III) had similar effects on
the activities of cathepsin B and NAG in both keratinocytes and
HaCaT cells with slightly increased enzyme activities in whole cell
homogenate and slightly decreased enzyme activities in endosomal
and lysosomal fractions as compared with the controls. This
tendency could be observed also in the case of cathepsin L. On the
other hand, cathepsin S activity showed a very different behavior,
which was similar for both cell types. Interestingly, cathepsin S
activity showed a several-fold higher increase in whole cell
homogenates (5-fold and 13-fold) than in endosomal and lysosomal
fractions (2±3-fold). This different behavior of cathepsin S in
comparison with that of the other lysosomal enzymes indicates the
special function of cathepsin S in parallel to the upregulation of
MHC class II molecules and invariant chain. This experiment
further demonstrates that the permanent human keratinocyte line
HaCaT may serve as a valuable tool to investigate immunologic
characteristics of human keratinocytes.
In order to examine the mechanism of increased cathepsin S
activity, we determined cathepsin S mRNA by reverse transcrip-
tion±PCR in control keratinocytes in comparison with keratino-
cytes stimulated with IFN-g (1000 U per ml) for 24 h. Figure 2
shows that this cytokine induced mRNA formation, whereas in
control cells cathepsin S mRNA was not detectable. Therefore,
induction of cathepsin S after 24 h of treatment with IFN-g was
shown, which was measurable as a several-fold increase in enzyme
activity after 72 h. In addition, we con®rmed this induction at the
protein level, not only in primary keratinocytes, but also in HaCaT
keratinocytes (Fig 3). Whereas cathepsin S was found by
immunoblotting in a crude organelle fraction of control HaCaT
Table II. Lysosomal enzyme activities in subcellular fractions of human keratinocytes (72 h control) in primary culture
(KC) and syngeneic EBV-transformed B cells (B) derived from one patienta
Cathepsin B Cathepsin L Cathepsin S NAG
K B KC B KC B KC B
H 21.8 6 2.5 1.9 6 0.3 0.2 6 0.0 1.8 6 0.1 0.01 6 0.00 0.03 6 0.00 44.6 6 10.4 12.9 6 0.5
D 24.9 6 0.9 2.3 6 0.1 0.6 6 0.1 1.4 6 0.0 0.01 6 0.00 0.01 6 0.00 89.2 6 23.0 12.1 6 0.1
E 73.0 6 5.5 4.4 6 0.4 13.3 6 3.3 3.2 6 0.7 0.06 6 0.03 0.39 6 0.10 130.9 6 83.9 23.5 6 2.1
L 269.0 6 1.0 34.7 6 2.1 11.6 6 1.7 23.0 6 5.0 0.15 6 0.03 0.78 6 0.21 247.7 6 128.9 147.3 6 26.6
M 7.3 6 0.3 2.1 6 0.9 0.3 6 0.2 0.9 6 0.3 ND 0.04 6 0.00 24.4 6 9.7 5.6 6 0.5
C 5.6 6 0.3 2.0 6 0.5 0.2 6 0.2 0.6 6 0.0 ND 0.05 6 0.01 20.3 6 0.8 2.0 6 0.1
aUnits per g protein, mean of two values. In case of the B cells two experiments were used for calculation. For keratinocytes one experiment with two determinations
was used. H, homogenate; D, debris; E, endosomal fraction; L, lysosomal fraction; M, microsomes; C, cytosol; ND, not detectable.
Table I. Lysosomal enzyme activities in subcellular
fractions of HaCaT keratinocytesa
Cathepsin B Cathepsin L Cathepsin S NAG
H 32.1 6 2.6 2.1 6 0.8 0.03 6 0.01 19.9 6 3.5
D 47.7 6 1.4 1.1 6 0.1 0.07 6 0.05 19.5 6 3.4
E 65.5 6 7.0 8.3 6 3.1 0.12 6 0.09 36.6 6 4.0
L 348.1 6 40.2 52.7 6 1.9 0.60 6 0.06 149.1 6 14.6
M 8.4 6 0.9 0.4 6 0.4 0.06 6 0.01 6.4 6 2.5
C 6.8 6 0.8 1.0 6 1.0 0.02 6 0.02 6.9 6 1.2
aUnits per g protein, mean of the values obtained from two experiments with at
least two determinations each. H, homogenate; D, debris; E, endosomal fraction;
L, lysosomal fraction; M, microsomes; C, cytosol.
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cells, the amount of enzyme protein was too low to be detected in
endosomal and lysosomal fractions of control primary keratino-
cytes; however, IFN-g treatment for 72 h resulted in a clearly
increased amount of cathepsin S protein in both HaCaT and
primary keratinocytes. As expected lysosomal keratinocyte fractions
did not contain the proform of cathepsin S (37 kDa), whereas in
the endosomes the newly synthesized enzyme was present in a
considerable amount as the enzymatically inactive proform.
DISCUSSION
Cathepsins are a family of lysosomal proteases involved in
intracellular protein degradation. Consequently, most of the
cathepsins are ubiquitously distributed and only some members
show a restriction to certain tissues. Cathepsin S belongs to this
group of restricted cathepsins, which is predominantly expressed in
lymphatic tissues (Kirschke et al, 1986). We have found cathepsin S
activity also in the spontaneously transformed human keratinocyte
cell line HaCaT as well as in freshly isolated human keratinocytes.
Endosomal/lysosomal cell compartments show, as expected,
highest activities.
Furthermore, in general protein turnover cathepsins are also
involved in the generation of antigenic peptides (Fineschi and
Miller, 1997; Nakagawa and Rudensky, 1999; Villadangos et al,
1999). It is suggested that this incomplete proteolysis takes place in
pre-lysosomal compartments (Authier et al, 1996); however,
con¯icting data exist regarding their exact role. Whereas
Matsunuga et al (1993) were able to block primary immune
responses by inhibition of cathepsin B, others demonstrated that
Figure 1. Neo-expression of MHC class II
and invariant chain upon IFN-g stimulaiton
in human keratinocytes. Effect of IFN-g
stimulation (1000 U per ml, 72 h) on expression
of MHC class I and II molecules and invariant
chain of freshly isolated human keratinocytes.
Filled pro®le = negative control; dark line =
without IFN-g stimulation; gray line = stimulated
with IFN-g.
Table III. Effect of IFN-g stimulation (1000 U per ml, 72 h) on lysosomal enzyme activities in subcellular fractions of
human keratinocytes in primary culture and HaCaT keratinocytesa
Cathepsin B Cathepsin L Cathepsin S NAG
KC HaCaT KC HaCaT KC HaCaT KC HaCaT
H 154.7 6 18.1 133.7 6 4.1 231.5 6 31.5 92.7 6 47.4 1364.3 6 1235.7 480.0 6 41.7 116.9 6 1.0 103.3 6 21.5
E 96.2 6 18.5 67.3 6 15.8 78.6 6 52.9 29.7 6 30.6 282.5 6 71.1 217.4 6 48.0 75.6 6 5.3 63.2 6 20.3
L 111.5 6 6.9 65.5 6 3.0 156.5 6 37.7 25.6 6 35.6 255.1 6 142.8 210.8 6 48.6 86.2 6 8.8 69.3 6 25.8
a% of controls, mean of the values obtained from two experiments with at least two determinations each. In the ®rst experiment keratinocytes from one patient were
used (see Table II). The keratinocytes in the second experiment were collected from four patients. In this experiment lysosomal enzyme activities of the 72 h controls were
in the same range as those of the ®rst experiment. H, homogenate; E, endosomal fraction; L, lysosomal fraction.
Figure 2. Induction of cathespin S in RNA in human
keratinocytes upon IFN-g stimulation. Reverse transcription±PCR
of human cathepsin S (a) and b-actin (b). (a) 1 = negative control
without RNA; 2 = negative control with 300 ng RNA/without reverse
transcriptase; 3±5 = cDNA 100, 200, 500 ng; 6 = negative control with
300 ng RNA/without reverse transcriptase; 7±9 cDNA 100, 200,
500 ng. (b) 1 = negative control without RNA; 2 = negative control
with 300 ng RNA and processed with DNase; 3 = negative control
300 ng RNA/without reverse transcriptase; 4 = 300 ng cDNA;
5 = negative control with 300 ng RNA with DNase processed;
6 = negative control 300 ng RNA without reverse transcriptase;
7 = 300 ng cDNA.
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antigen presentation is detectable also in mice de®cient for either
cathepsin B or S (Villadangos et al, 1997), thus arguing for the
presence of alternative systems to take over the part of these
cathepsins in antigen processing.
Keratinocytes are an integral part of the skin immune system.
Although they do not express MHC class II molecules constitu-
tively, exposure to IFN-g can induce expression of these markers
thus enabling them to function as nonprofessional antigen-
presenting cells (Nickoloff and Turka, 1994). Our ®nding of the
presence of high cathepsin B activity, lower cathepsin L activity,
and very low cathepsin S activity indicates a more speci®c function
of the latter. This may be an immunogenic function, which appears
to be demonstrated by the relatively high cathepsin S activity in
syngeneic B cells when compared with the activities of cathepsins B
and L. Furthermore, the high ratio of endosomal to lysosomal
cathepsin S activity in these professional antigen-presenting cells
supports this immunogenic function. In endosomal compartments
antigenic peptide loading is possible after the cleavage of invariant
chain by the catalysis of cathepsin S (Riese et al, 1996). The concept
is further supported by the selective increase in cathepsin S activity
in HaCaT and primary keratinocytes, when MHC class II
molecules are de novo expressed under the in¯uence of IFN-g.
Under these conditions, the activities of the house-keeping
proteinases, cathepsins B and L, were not increased. Interestingly,
endosomal and lysosomal cathepsin S activities were changed very
similarly in both primary and HaCat keratinocytes. The ®nding of
5±13-fold activity increases in whole cell lysates of both cell types
points to a decrease of cytosolic proteinase inhibitors, which may
be heterogeneous in the two preparations of primary keratinocytes
examined. This may be substantiated by the ®nding of slightly
increased activities of cathepsins B and L, but unchanged NAG
activities. Whereas NAG is not known to be inhibited by cytosolic
proteins, their inhibitory potential on cathepsins B and L is lower
than that on cathepsin S (Abrahamson, 1994). These ®ndings
demonstrate that IFN-g treatment of keratinocytes had differential
effects on the activities on endosomal/lysosomal cathepsins B, L,
and S as well as on their cytosolic inhibitors.
The mechanisms underlying the increase in cathepsin S activity
upon stimulation of HaCaT and primary keratinocytes with IFN-g
for 72 h was found to be an increased expression of cathepsin S
protein, which was found to be preceded by increased mRNA
expression after 24 h of IFN-g treatment. This induction parallels de
novo expression of MHC class II molecules and invariant chain
(Albanesi et al, 1998) and may be mediated through AP1 binding
sites on the cathepsin S promoter (Shi et al, 1994). Whereas
lysosomal cathepsin S activity appears to re¯ect the amount of
cathepsin S protein, the endosomal fraction (composed of early and
late compartments with different maturation states of cathepsins)
contains both active cathepsin S and the inactive proform. Thus, in
addition to the presence of the active enzyme a pool of preformed
cathepsin S may be capable of being rapidly activated when
cleavage of the invariant chain is required for maturation of MHC
class II molecules within the endosomal compartment.
IFN-g is believed to be a key cytokine in the induction phase of
psoriasis (Szabo et al, 1998) where keratinocytes typically exhibit an
MHC class II positive phenotype (Gottlieb et al, 1986). Several
studies have demonstrated increased proteinase activities in psoriatic
epidermis (Baird et al, 1990; Wiedow et al, 1992). More recently,
processing of precursor forms of cathepsins L, B, and D to mature
enzymes has been demonstrated in psoriasis (Kawada et al, 1997). As
cathepsin S is involved in the proteolysis of the invariant chain
(Riese et al, 1996) its induction might be of major importance in
the context of antigen presentation. IFN-g induced upregulation of
cathepsin S activity in keratinocytes might therefore be an
important feature in the pathogenesis of psoriasis where these
cells are candidates to present a putative (auto-)antigen to T cells
(Boehncke, 1996; Prinz et al, 1999).
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